UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Potential interactions between alternative therapies and warfarin

American journal of health-system pharmacy, 2000-07, Vol.57 (13), p.1221-1230

2000

Volltextzugriff (PDF)

The Handbook of Technology Foresight: Concepts and Practice

2008

Volltextzugriff (PDF)

Integral Representation Theory: Applications to Convexity, Banach Spaces and Potential Theory

1. Aufl., 2010

Volltextzugriff (PDF)

Quantitative Crystallinity Determinations for β-Lactam Antibiotics by Solution Calorimetry: Correlations with Stability

Journal of pharmaceutical sciences, 1978-06, Vol.67 (6), p.767-773

1978

Volltextzugriff (PDF)

Thermal Decomposition of Amorphous β-Lactam Antibacterials

Journal of pharmaceutical sciences, 1977-09, Vol.66 (9), p.1312-1316

1977

Volltextzugriff (PDF)

Effect of Nitroglycerin-Soluble Additives on the Stability of Molded Nitroglycerin Tablets

Journal of pharmaceutical sciences, 1984-11, Vol.73 (11), p.1608-1612

1984

Volltextzugriff (PDF)

Vapor Pressure of Nitroglycerin in Sublingual Molded Tablets: Implications for Stability

Journal of pharmaceutical sciences, 1976-09, Vol.65 (9), p.1278-1284

1976

Volltextzugriff (PDF)

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

The New England journal of medicine, 2021-02, Vol.384 (7), p.630-642

2021

Volltextzugriff (PDF)

The Sword of Ambition: Bureaucratic Rivalry in Medieval Egypt

1, 2019

Volltextzugriff (PDF)

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

International journal of gynecology and obstetrics, 2024-05, Vol.165 (2), p.431-441

2024

Volltextzugriff (PDF)

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

Obstetrics and gynecology (New York. 1953), 2022-12, Vol.140 (6), p.920

2022

Volltextzugriff (PDF)

Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials

American journal of obstetrics and gynecology, 2023-03, Vol.228 (3), p.320.e1-320.e11

2023

Volltextzugriff (PDF)

Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials

Obstetrics and gynecology (New York. 1953), 2022-06, Vol.139 (6), p.1070-1081

2022

Volltextzugriff (PDF)

LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS

Fertility and sterility, 2020-09, Vol.114 (3), p.e1-e1

2020

Volltextzugriff (PDF)

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

American journal of obstetrics and gynecology, 2023-12, Vol.229 (6), p.662.e1-662.e25

2023

Volltextzugriff (PDF)

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study

American journal of obstetrics and gynecology, 2024-02, Vol.230 (2), p.237.e1-237.e11

2024

Volltextzugriff (PDF)

O-191 Effects of relugolix combination therapy (Relugolix-CT) on uterine fibroid (UF) and uterine volume through 52 weeks: post hoc analysis of the LIBERTY Long-Term Extension study

Human reproduction (Oxford), 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Thiazole Based Carbohydrazide Derivatives as α-Amylase Inhibitor and Their Molecular Docking Study

Heteroatom chemistry, 2019, Vol.2019 (2019), p.1-8

2019

Volltextzugriff (PDF)

Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary

Journal of comparative effectiveness research, 2024-08, Vol.13 (8), p.e230194

2024

Volltextzugriff (PDF)

Bleeding Patterns in Women With Uterine Fibroids Receiving Relugolix Combination Therapy Over 1 Year [A78]

Obstetrics and gynecology (New York. 1953), 2022-05, Vol.139 (1), p.23-23S

2022

Volltextzugriff (PDF)

Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location [A77]

Obstetrics and gynecology (New York. 1953), 2022-05, Vol.139 (1), p.23-23S

2022

Volltextzugriff (PDF)

Relugolix Combination Therapy Reduced Uterine Fibroid-Associated Pain in Two Phase 3 LIBERTY Studies [32B]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.27-27S

2020

Volltextzugriff (PDF)

A plain language summary of the long-term relugolix combination therapy study for uterine fibroids

Journal of comparative effectiveness research, 2023-08, Vol.12 (8), p.CER-e230069

2023

Volltextzugriff (PDF)

Effects of Relugolix-CT on Uterine Fibroid (UF) and Uterine Volume through 52 Weeks: Liberty Long-Term Extension (LTE) Post Hoc Analysis

Journal of minimally invasive gynecology, 2023-11, Vol.30 (11), p.S5

2023

Volltextzugriff (PDF)

Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location over 24 Weeks

Journal of minimally invasive gynecology, 2022-11, Vol.29 (11), p.S1-S1

2022

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Englisch
(133)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Potential interactions between alternative therapies and warfarin

The Handbook of Technology Foresight: Concepts and Practice

Integral Representation Theory: Applications to Convexity, Banach Spaces and Potential Theory

Quantitative Crystallinity Determinations for β-Lactam Antibiotics by Solution Calorimetry: Correlations with Stability

Thermal Decomposition of Amorphous β-Lactam Antibacterials

Effect of Nitroglycerin-Soluble Additives on the Stability of Molded Nitroglycerin Tablets

Vapor Pressure of Nitroglycerin in Sublingual Molded Tablets: Implications for Stability

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

The Sword of Ambition: Bureaucratic Rivalry in Medieval Egypt

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials

Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials

LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study

O-191 Effects of relugolix combination therapy (Relugolix-CT) on uterine fibroid (UF) and uterine volume through 52 weeks: post hoc analysis of the LIBERTY Long-Term Extension study

Thiazole Based Carbohydrazide Derivatives as α-Amylase Inhibitor and Their Molecular Docking Study

Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary

Bleeding Patterns in Women With Uterine Fibroids Receiving Relugolix Combination Therapy Over 1 Year [A78]

Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location [A77]

Relugolix Combination Therapy Reduced Uterine Fibroid-Associated Pain in Two Phase 3 LIBERTY Studies [32B]

A plain language summary of the long-term relugolix combination therapy study for uterine fibroids

Effects of Relugolix-CT on Uterine Fibroid (UF) and Uterine Volume through 52 Weeks: Liberty Long-Term Extension (LTE) Post Hoc Analysis

Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location over 24 Weeks

Suchergebnisse filtern